Two companies aiming to create an artificial “embryo” by merging the nucleus
of a human cell with a pig egg have abandoned their attempt to patent the
process after a Greenpeace exposé. “It was never our intention to claim
patents that would cover human embryos or human reproductive cloning,” says
Julia Greenstein of BioTransplant in Charlestown, Massachusetts. Both companies
deny the decision was in response to the Greenpeace campaign, but the pressure
group is claiming victory. “These are the first biotech companies to admit
having gone too far in claiming patents on human embryos,” it says in a press
release.
More from New Scientist
Explore the latest news, articles and features
Physics
Record-breaking, fast-spinning magnet could help uncover new physics
News
Environment
An unexpected feedback loop may be driving mega heatwaves
News
91ɫÇéƬ
Less than 4 minutes of vigorous exercise a day could halve your dementia risk
News
91ɫÇéƬ
Parkinson’s may be driven by ‘vicious cycle’ that disrupts brain waste drainage
News
Popular articles
Trending New Scientist articles